1241 (1241) Fair Value & Analysis

Consumer Cyclical · Market cap HK$78.7M

1 1241 1241 · HK

PriceHK$0.1210

Fair ValueHK$0.1300

Upside+7.4%

Quality44/100

Evidence: Low Range HK$0.0800 – HK$0.1600

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −6.9% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1020 – HK$0.2500 · fair‑value band HK$0.0800 – HK$0.1600 · the HK$0.1210 price screens below the HK$0.1300 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1241 (1241) currently trades at HK$0.1210, while our model-based Fair Value estimate is HK$0.1300 — implying the stock looks roughly 7.4% undervalued today. We read business quality at 44/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 1241 generated revenue of HK$45.5M at a net margin of -41.4%. Revenue grew 47.1% year over year. It earns a return on equity of -7.5%. The balance sheet holds a net cash position of HK$77.6M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$45.5M

Revenue growth (YoY) +47.1%

Net margin -41.4%

Return on equity -7.5%

Free cash flow −HK$1.8M FY2025

Operating margin -36.6%

More key figures

Net cash HK$77.6M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1241 reported revenue of HK$45.5M in FY2025 versus HK$32.7M in FY2021, a compound +8.6%/yr. Reported net income was −HK$18.8M in FY2025.

Revenue +8.6%/yr

FY21 HK$32.7M

FY22 HK$20.4M

FY23 HK$101M

FY24 HK$82.8M

FY25 HK$45.5M

Net income

FY21 −HK$18.6M

FY22 −HK$19.9M

FY23 −HK$12.1M

FY24 −HK$16.9M

FY25 −HK$18.8M

Is 1241 fairly valued? → Check now

Similar stocks

6 more Auto Parts stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
O'Reilly Automotive, Inc ORLY34	R$1.49	R$0.4900	-67%
AutoZone, Inc AZOI34	R$73.14	R$10.17	-86%
Hyundai Mobis Co 012330	570,000 KRW	591,992 KRW	+4%
Fuyao Glass Industry Group 600660	¥50.05	¥111.37	+123%
Magna International Inc MGAN	1,182 MXN	1,064 MXN	-10%
Ningbo Tuopu Group 601689	¥63.21	¥19.12	-70%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1241 (1241) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1300 versus a price of HK$0.1210 — about +7% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1241?

Our model-based fair value for 1241 is HK$0.1300 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1210.

What is the quality score of 1241?

1241 has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1241 (1241)?

1241 reported trailing-twelve-month revenue of about HK$45.5M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1241?

The net profit margin of 1241 is about -41.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.